Headlines
  • Since the US-Iran deal was announced on Sunday, Iran's army claims that Israel has violating the ceasefire in southern Lebanon 84 times. The aggressor "should expect a harsh response" if the attacks persist, according to the army.
  • Switzerland said that an initial deal between the US and Iran would be signed in Lucerne on Friday.
  • US President Trump said that the deal implies Iran won't have nuclear weapons while speaking at the G7 summit.
  • US president Trump said that Israeli Prime Minister Netanyahu needs to deal with Hezbollah in Lebanon in a "more responsible" way.
  • An alleged targeted acid attack in New Jersey injured six people, including three teenagers.
  • A manhunt is underway for the alleged shooter who reportedly shot two coworkers at a Delaware hospital on Tuesday.

Tag: Malaria

July 30, 2024

Scientists Warn Urgent Action Needed to...

In some parts of Africa, the primary treatment for malaria, artemisinin, is becoming less effective against the parasite that causes the disease. Without immediate changes in health policy, a new analysis warns that millions more deaths could occur.

August 13, 2021

Malaria Free VIllage in Malawi

Last year, Malawi had nearly seven million malaria cases, accounting for nearly a third of the population, with 2,500 people lost their lives as a result of the mosquito-borne diseases. However, one village has become a model for malaria eradication, and was recognised in June as the first to have zero malaria cases for a whole year

May 21, 2021

To Curb Malaria Burkina Faso Tests...

Malaria vaccines produced in Burkina Faso aren’t the only ones being tested in the country to combat the mosquito-borne disease. Scientists in the West African country have been breeding genetically engineered mosquitos with the aim of reducing mosquito populations’ ability to transmit malaria

April 24, 2021

Africa Malaria Vaccine

In an exclusive interview with VOA, the director of Oxford University’s Jenner Institute says their new malaria vaccine, tested in Burkina Faso, has shown a preliminary efficacy rate of 77%, which could help prevent over 400,000 deaths a year, most of them in sub-Saharan Africa

Top